Dr. Huaizheng Peng is a Director of the Board and General Manager International Operations for China Medical System Holdings.
Prior to that, he was a director of corporate finance and head of life sciences at Seymour Pierce, a leading London-based investment bank.
From 1999 to 2007, Dr. Peng was a senior portfolio manager, specializing in global life science and Asian technology investment in Reabourne Technology Investment Management Company (now part of Close Brothers Asset Management Company).
Bachelor (84) and Masters (89) of Medicine from Hunan Medical University in Changsha, Hunan, Master of Medicine. PhD in Molecular Pathology from University College London (UCL) Medical School, London, UK, in 1998 and practiced as a clinical lecturer at the UCL Medical School, London, UK.